Studying of the expression of PERP protein in the skin of patients with pemphigus
- 作者: KUBANOV AA1,2, KATUNINA OR1, MICHENKO AV1, ABRAMOVA TV2
-
隶属关系:
- State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
- Russian Medical Academy of Postgraduate Studies, Ministry of Health of the Russian Federation
- 期: 卷 89, 编号 6 (2013)
- 页面: 59-65
- 栏目: Articles
- URL: https://ogarev-online.ru/0042-4609/article/view/117082
- DOI: https://doi.org/10.25208/vdv599
- ID: 117082
如何引用文章
全文:
详细
作者简介
A KUBANOV
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation; Russian Medical Academy of Postgraduate Studies, Ministry of Health of the Russian Federationд.м.н., профессор, зам. директора по научной работе, зав. кафедрой дерматовенерологии, микологии и косметологии
O KATUNINA
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federationд.м.н., доцент, зав. лабораторией патоморфологии
A MICHENKO
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: michenko@cnikvi.ru
к.м.н., старший научный сотрудник отдела дерматологии
T ABRAMOVA
Russian Medical Academy of Postgraduate Studies, Ministry of Health of the Russian Federationк.м.н., доцент кафедры дерматовенерологии, микологии и косметологии
参考
- Самцов А.В., Белоусова И.Э. Буллезные дерматозы. СПб: Коста 2012; 143
- Теплюк Н.П. Потекаев Н.Н., Кузьмина Т.С. и др. Летальный исход при кортикостероидной терапии акантолитической пузырчатки в результате инфекционных осложнений. Клин дерматол венерол 2005; 2: 16—20
- Матушевская Е.В., Лысенко А.А., Свирищевская Е.В. Клинические особенности и иммунные механизмы патогенеза истинной пузырчатки. Совр пробл дерматовенерол иммунол врачебн косметол 2006; 1: 18—26
- Langan S.M., Smeeth L., Hubbard R. et al. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. BMJ. 2008; 337: a180
- Robinson J.C., Lozada-Nur F., and Frieden I. Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84, 349—355
- Дерматовенерология, 2010. (Клинические рекомендации Российское общество дерматовенерологов) [под ред. А.А. Кубановой]. М: ДЭКС-ПРЕСС 2010; 428
- Ahmed A.R., Moy R. Death in pemphigus. J Am Acad Dermatol 1982; 7: 221—228
- Rosenberg F.R., Sanders S., Nelson C. T. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976; 112: 962—970.
- Grando S.A. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity 2012; 45: 1: 7—35.
- Сербин М.Е., Щербак Е.В. Апоптоз и его молекулярные эффекторы. Актуальные проблемы биологии, медицины и экологии: Сборник / под ред. проф., д.м.н. Н.Н. Ильинских. Томск: Сибирский государственный медицинский университет 2004; 1
- Milner Y., Metezeau P., Kiefer H. et al. Pemphigus an autoimmune disease of the skin: cell-cell separation versus membrane signaling and apoptosis in acantholysis. The Decade of Autoimmunity. Ed. by Y. Shoenfeld. Amsterdam, Elsevier Science BV, 1999, pp 606—615.
- Puviani M., Marconi A., Cozzani E., Pincelli C. Fas ligand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J Invest Dermatol 2003, 120: 164—167.
- Pelacho B., Natal C., Espana A. et al. Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett 2004, 566: 6—10.
- Pretel M., Espafla A., Marquina M. et al. An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris. Exp Dermatol. 2009; 18 (9): 771—780.
- Grando S.A., Bystryn J.C., Chernyavsky A.I. et al. Apoptolysis: A novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp Dermatol 2009; 18: 764—770.
- Frusic-Zlotkin M., Pergamentz R., Michel B. et al. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients. Ann Ny Acad Sci 2005, 1050: 371—379.
- Arredondo J., Chernyavsky A.I., Karaouni A., Grando S.A. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus. Am J Pathol 2005; 167: 1531—1544.
- Барышников А.Ю., Шишкин Ю.В. Иммунологические проблемы апоптоза. М: Эдиториал УРСС, 2002; 320
- Wang X., Bregegere F., Frusic-Zlotkin M. et al. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 2004, 9: 131—143.
- Wang X., Bregegere F., Soroka Y. et al. Replicative senescence enhances apoptosis induced by pemphigus autoimmune antibodies in human keratinocytes. FEBS Lett 2004, 567: 281—286.
- Attardi L.D., Reczek E.E. Cosmas C. et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 2000; 14: 6: 704—718.
- Ihrie R.A., Marques M.R., Nguyen B.T. et al. Perp is a p63-regulated gene essential for epithelial integrity. Cell 2005; 120: 843—856.
- Bektas M., Rubenstein D.S. Perp and pemphigus: a disease of desmosome destabilization. J Invest Dermatol 2009; 129: 1606—1608.
补充文件
